Antiretroviral News and Research RSS Feed - Antiretroviral News and Research

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Scientists at the National Institutes of Health and Emory University have experimentally induced sustained remission of SIV, the simian form of HIV, in infected monkeys. [More]
New amfAR report highlights role of health plans, health care purchasers in curbing domestic HIV epidemic

New amfAR report highlights role of health plans, health care purchasers in curbing domestic HIV epidemic

Today, amfAR, The Foundation for AIDS Research released a new report, “Curbing the HIV Epidemic by Supporting Effective Engagement in HIV Care: Recommendations for Health Plans and Health Care Purchasers,” which highlights the critical role of health plans and health care purchasers, including Medicaid and Medicare programs, marketplaces, and employers, in moving the nation toward ending the domestic HIV epidemic. [More]
WHO: Countries need to move much faster to prevent, detect and treat TB to meet global targets

WHO: Countries need to move much faster to prevent, detect and treat TB to meet global targets

New data published by the World Health Organization (WHO) in its 2016 Global Tuberculosis (TB) Report show that countries need to move much faster to prevent, detect and treat the disease if they are to meet global targets. [More]
CCN article outlines unique treatment options for cardiovascular patients with HIV

CCN article outlines unique treatment options for cardiovascular patients with HIV

Cardiovascular disease has become the leading cause of death for those living with HIV, as the infection has moved from a terminal disease to a chronic illness. [More]
New project clarifies molecular processes involved in hidden HIV reservoir

New project clarifies molecular processes involved in hidden HIV reservoir

In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. [More]
UNC secures $18 million NIH funding to form iTech for facilitating HIV research studies

UNC secures $18 million NIH funding to form iTech for facilitating HIV research studies

People under the age of 30 account for the majority, or 40 percent, of new HIV infections in the United States. [More]
Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. [More]
Researchers develop innovative technique for detecting HIV hiding places in infected patients

Researchers develop innovative technique for detecting HIV hiding places in infected patients

Discovery of a novel, advanced technique to identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for a HIV/AIDS cure. [More]
Gut bacteria may play role in immune recovery of HIV patients

Gut bacteria may play role in immune recovery of HIV patients

An international study coordinated by Spanish research institutes has found that gut bacteria also play their role in the immune recovery of HIV patients. [More]
HIV-infected adults with MDD more likely to experience heart attack, study shows

HIV-infected adults with MDD more likely to experience heart attack, study shows

Among more than 26,000 human immunodeficiency virus (HIV)-infected adults, those with major depressive disorder (MDD) were more likely to experience a heart attack than those without MDD, according to a study published online by JAMA Cardiology. [More]
New method estimates patient adherence to antiretroviral drugs

New method estimates patient adherence to antiretroviral drugs

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz have developed a technique that estimates an HIVnegative patient's adherence to drugs prescribed to prevent HIV transmission during sex. [More]
Added benefit of combination drug for HIV-infected patients not proven

Added benefit of combination drug for HIV-infected patients not proven

The drug combination emtricitabine/tenofovir alafenamide is approved in combination with other antiviral agents for the treatment of adults and adolescents infected with human immunodeficiency virus type 1 (HIV-1). [More]
Research could provide new insights into finding cure for chronic infections

Research could provide new insights into finding cure for chronic infections

New research has taken us a step closer to finding a cure for human immunodeficiency virus (HIV), as well as other infections including the glandular fever virus, which is associated with the development of lymphoma. [More]
Study shows link between inflammatory biomarkers and prevalence of CAD in HIV-infected men

Study shows link between inflammatory biomarkers and prevalence of CAD in HIV-infected men

A cardiac imaging study led by Hossein Bahrami, MD, PhD, assistant professor of cardiovascular medicine at the Keck School of Medicine of the University of Southern California, along with investigators from Johns Hopkins University and five other institutions, showed a correlation between higher inflammatory biomarkers and an increased prevalence of coronary artery disease (CAD) in men infected with human immunodeficiency virus (HIV). [More]
Early initiation of antiretroviral therapy can considerably reduce total HIV DNA levels

Early initiation of antiretroviral therapy can considerably reduce total HIV DNA levels

A team of researchers, led by Drs. Merlin Robb and Jintanat Ananworanich of the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research, has found that when antiretroviral therapy (ART) is initiated during early acute HIV infection, it can significantly reduce total HIV DNA levels in the body, which may have implications for the goal of achieving long-term HIV remission. [More]
CD4/CD8 ratio biomarker could help identify HIV-infected individuals at risk for heart disease

CD4/CD8 ratio biomarker could help identify HIV-infected individuals at risk for heart disease

The ratio of CD4 to CD8 T cells in the blood-a marker of immune system health and associated with mortality risk in the general population-is an independent predictor of coronary heart disease in HIV-infected patients, according to a new study published in AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. [More]
Maternal HIV infection could alter gut microbiome of HIV-exposed, uninfected infants

Maternal HIV infection could alter gut microbiome of HIV-exposed, uninfected infants

A study led by researchers at The Saban Research Institute of Children's Hospital Los Angeles suggests that maternal HIV infection influences the microbiome of their HIV-uninfected infants. [More]
Combining ART with immune-enhancing treatment may destabilize HIV reservoirs

Combining ART with immune-enhancing treatment may destabilize HIV reservoirs

Although antiretroviral therapy (ART) can reduce the amount of HIV in the blood to an undetectable level in most chronically infected people, it cannot eliminate reservoirs of HIV that persist in latently infected immune cells. [More]
Improving efficiency of health facilities could extend ART to many people living with HIV

Improving efficiency of health facilities could extend ART to many people living with HIV

Health facilities in Kenya, Uganda, and Zambia could extend life-sustaining antiretroviral therapy (ART) to hundreds of thousands of people living with HIV if facilities improved the efficiency of service delivery. [More]
Study provides new insights into real-world use of PrEP

Study provides new insights into real-world use of PrEP

Several studies presented today in an official press conference at the 21st International AIDS Conference in Durban provided new insights on the use of PrEP among a broad range of populations. [More]
Advertisement
Advertisement